Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
2.53 USD
117.79 M USD
1.22 B USD
12.11 M
About Dermapharm Holding SE
Sector
Industry
CEO
Hans-Georg Feldmeier
Website
Headquarters
Grunwald
Founded
2017
IPO date
Feb 9, 2018
Identifiers
2
ISIN DE000A2GS5D8
Dermapharm Holding SE engages in the development, manufacture and market of patent-free pharmaceutical products. The company operates through the Branded pharmaceuticals and other healthcare products, Parallel import business and Herbal extracts divisions. Its products include covers prescription pharmaceuticals (Rx), over-the-counter (OTC) products, medical devices, food supplements and cosmetics. The company was founded in 1991 and is headquartered in Grunwald, Germany.
Related stocks
Broadening rising wedge - and company future perspectiveAfter the DMP Stock touched and rebounced from it's 52-Week support at 36,00€, it is now creating a broadening rising wedge formation. As from market perspective, this formation can be attributed to high uncertainty as well as worsening growth perspective for the Euro-Zone.
Mid-term perspective for
See all ideas
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
EMUSC.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR acc- CapitalisationWeight
0.10%
Market value
841.08 K
USD
EMUSCD.EUR
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR Ukdis- DistributionWeight
0.10%
Market value
841.08 K
USD
UEFD
UBS (Lux) Fund Solutions SICAV - UBS MSCI EMU Small Cap UCITS ETF EUR dis- DistributionWeight
0.10%
Market value
841.08 K
USD
X026
Amundi MSCI Europe Small Cap ESG Broad Transition UCITS ETF DistWeight
0.19%
Market value
482.11 K
USD
Explore more ETFs
Frequently Asked Questions
The current price of DMPHF is 39.56 USD — it has decreased by −7.32% in the past 24 hours. Watch Dermapharm Hldg SE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Dermapharm Hldg SE stocks are traded under the ticker DMPHF.
We've gathered analysts' opinions on Dermapharm Hldg SE future price: according to them, DMPHF price has a max estimate of 57.78 USD and a min estimate of 40.93 USD. Watch DMPHF chart and read a more detailed Dermapharm Hldg SE stock forecast: see what analysts think of Dermapharm Hldg SE and suggest that you do with its stocks.
DMPHF reached its all-time high on Nov 29, 2022 with the price of 42.68 USD, and its all-time low was 39.56 USD and was reached on Mar 27, 2025. View more price dynamics on DMPHF chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
DMPHF stock is 7.90% volatile and has beta coefficient of 0.53. Track Dermapharm Hldg SE stock price on the chart and check out the list of the most volatile stocks — is Dermapharm Hldg SE there?
Today Dermapharm Hldg SE has the market capitalization of 2.36 B, it has decreased by −7.77% over the last week.
Yes, you can track Dermapharm Hldg SE financials in yearly and quarterly reports right on TradingView.
Dermapharm Hldg SE is going to release the next earnings report on Apr 15, 2026. Keep track of upcoming events with our Earnings Calendar.
Dermapharm Hldg SE revenue for the last quarter amounts to 346.05 M USD, despite the estimated figure of 354.26 M USD. In the next quarter, revenue is expected to reach 349.89 M USD.
DMPHF net income for the last quarter is 48.38 M USD, while the quarter before that showed 24.61 M USD of net income which accounts for 96.54% change. Track more Dermapharm Hldg SE financial stats to get the full picture.
Yes, DMPHF dividends are paid annually. The last dividend per share was 1.05 USD. As of today, Dividend Yield (TTM)% is 2.44%. Tracking Dermapharm Hldg SE dividends might help you take more informed decisions.
Dermapharm Hldg SE dividend yield was 2.31% in 2024, and payout ratio reached 42.59%. The year before the numbers were 2.08% and 75.97% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Feb 14, 2026, the company has 3.6 K employees. See our rating of the largest employees — is Dermapharm Hldg SE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Dermapharm Hldg SE EBITDA is 352.30 M USD, and current EBITDA margin is 25.23%. See more stats in Dermapharm Hldg SE financial statements.
Like other stocks, DMPHF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Dermapharm Hldg SE stock right from TradingView charts — choose your broker and connect to your account.

